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Abstract
The airway epithelium in human plays a central role as the first line of defense against envi-
ronmental contaminants. Most respiratory diseases such as chronic obstructive pulmonary
disease (COPD), asthma, and respiratory infections, disturb normal muco-ciliary functions
by stimulating the hypersecretion of mucus. Several muco-active agents have been used to
treat hypersecretion symptoms in patients. Current muco-active reagents control mucus
secretion by modulating either airway inflammation, cholinergic parasympathetic nerve
activities or by reducing the viscosity by cleaving crosslinking in mucin and digesting DNAs
in mucus. However, none of the current medication regulates mucus secretion by directly
targeting airway goblet cells. The major hurdle for screening potential muco-active agents
that directly affect the goblet cells, is the unavailability of in vivo model systems suitable for
high-throughput screening. In this study, we developed a high-throughput in vivo model sys-
tem for identifying muco-active reagents using Xenopus laevis embryos. We tested mucus
secretion under various conditions and developed a screening strategy to identify potential
muco-regulators. Using this novel screening technique, we identified narasin as a potential
muco-regulator. Narasin treatment of developing Xenopus embryos significantly reduced
mucus secretion. Furthermore, the human lung epithelial cell line, Calu-3, responded simi-
larly to narasin treatment, validating our technique for discovering muco-active reagents.
Introduction
The muco-ciliary epithelium of the airway tract is one of the most vulnerable tissues which are
constantly challenged by external pathogens or contaminants. The airway epithelium consists
of several cell types, such as the mucus secreting goblet cells, multi-ciliated cells, and basal
cells [1]. The goblet cells synthesize and secrete mucus components such as mucin protein
(Muc5AC or Muc5B in mammals), whereas the cilia of the motile ciliated cells expectorate
the mucoid fluid, and the basal cells possibly possess a differentiation potential [1]. Mucus
hypersecretion is one of the major symptoms of respiratory diseases such as asthma, chronic
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obstructive pulmonary disease (COPD), cystic fibrosis and respiratory infections [2]. Most
medications for reducing mucus hypersecretion either alleviate inflammation, indirectly regu-
late mucus secretion as in the case of steroids, or reduce the viscosity of mucus to facilitate
expectoration by reducing the disulfide bond of mucin as in the case of N-acetylcysteine or by
digesting DNAs in the mucus as in the case of dornase [3]. Current experimental models for
studying the activities of muco-regulators, including mouse tracheal primary cultures and
human bronchial epithelial culture, are excellent for investigating the pathophysiology of
mucus production and secretion. However, these techniques are labor, resource, and time-
intensive [4]. Thus, current experimental models are not adequate for unbiased high through-
put screening-based and unbiased drug discovery.
The Xenopus embryonic epidermis is an emerging in vivo model system with several advan-
tages for studying the muco-ciliary epithelium. The embryonic epidermis of Xenopus is com-
posed of multiciliated cells, goblet cells, ionocytes, and small secretory cells [5]. The similarity
of the multiciliated cells of the Xenopus embryonic epidermis to those of mammalian multici-
liated cells facilitated research on muticilia formation [6, 7]. Although the Muc genes in
amphibians are highly evolved, differ from those of mammals, and are yet to be fully character-
ized [8], recent studies have further verified that the goblet cells of the Xenopus embryonic epi-
dermis are tractable, and constitute an accessible model for investigating mucus secretion [5,
9, 10].
In this study, we developed a unique high-throughput screening strategy for identifying
muco-active reagents using Xenopus laevis embryos. Using this unbiased screening technique,
we showed that several known muco-regulators function in similar ways in the Xenopus
muco-ciliary epithelium. Furthermore, we identified a new muco-active reagent, narasin. Nar-
asin is a potent inhibitor of mucus secretion in both Xenopus epidermis and the human lung
epithelial cell line, Calu-3. We believe that the screening technique developed in this study
would benefit researchers studying the pathophysiology of mucus-related disorders.
Materials and methods
Ethics statement
The Animal Care and Use Committee from the Institutional Review Board of Ulsan National
Institute of Science and Technology (UNIST) approved this work (Reference number, UNI-
STACUC-16-14). This study was performed in accordance with documented standards of the
Animal Care and Use Committee from the Institutional Review Board of UNIST. All members
of the research group attended educational and training courses for care and use of experimen-
tal animals. Adult Xenopus laeviswere housed under 12-h light/dark cycles at 18˚C in contain-
ers according to the guidance of Animal Care and Use Committee from the Institutional
Review Board of UNIST.
Xenopus embryo manipulation
Adult Xenopus laeviswere obtained from Nasco (U.S.A). The average age of the Xenopus laevis
is less than 5 years old and frogs were fed three times in a week with trout pellets from a local
supplier. Xenopus were housed in the XR4 husbandry system (aquatic habitats) with a 12-hour
light and 12-hour dark cycle. 12 frogs were housed in a 40 liter tank. The water quality for the
system was set to the manufacturer’s recommendation (Temperature; 18˚C, Conductivity;
1800 μS, pH; 7.0). Human chorionic gonadotropin (HCG) was used to trigger ovulation in
an adult female one day before the experiments and the animal was squeezed to release the
oocytes. A dissected testis from an adult male was used to fertilize the ovulated eggs. Cysteine
solution (2.5%, pH 7.9) was used to remove the jelly layer encasing the eggs and the fertilized
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eggs were grown in 1/3× MMR until stage 32. For the ELLA (Enzyme-Linked Lectin Assay)
analysis, four of the St. 32 embryos were nourished in 48 multi-well plates and the media from
the wells were collected for further ELLA analysis. At least 5 independent experiments were
performed for each condition.
WGA-HRP-based mucus measurement
Stage 32 sibling embryos were washed vigorously several times in 1/3× MMR (33mM NaCl,
0.6mM KCl, 0.3mM MgCl2, 1.6mM HEPES) to clear the secreted mucus particles. After wash-
ing, the embryos were incubated for 3 hours in 1/3× MMR containing each library compound
in a 48-well plate with a mesh-attached chamber. We used the SCREEN-WELL natural prod-
uct library (Enzo BML-2865) and 10 mM Diversity Set provided by the National Cancer Insti-
tute’s (NCI) Developmental Therapeutic Program’s Open Compound Repository. Then, the
treated embryos were moved into fresh media without the compounds for an hour, following
which the media was collected into a 96-well plate with a U-shaped bottom. The collected
media was incubated at 4˚C overnight. After incubation, the 96-well plate was washed twice
with PTW (1× PBS, 0.1% Tween-20), followed by incubation in 1% bovine serum albumin
(BSA) for an hour. After incubation, HRP-conjugated wheat germ agglutinin (WGA) (diluted
as 1/10,000 in 1% BSA) was added and incubated for an hour. After binding, the samples were
washed twice with PTW. Then, one tablet of o-phenylenediamine dihydrochloride (Sigma
P8287) in phosphate citrate buffer (0.1 M dibasic sodium phosphate, 0.05 M sodium citrate,
pH 5.0) was used for chromogenic detection. The reaction was stopped using 2.5 N sulfuric
acid. The intensity was measured using a microplate reader at 492 nm. Z score was used to cal-
culate the differences in detected mucus level with respect to the average, which was set at
zero.
The Z-score is calculated as in the formula below:
Z-score = (x– μ) / σ
x; Raw measurement, μ; Mean, σ; Standard deviation
Immunofluorescence and microscopy
For immunofluorescence microscopy, the embryos were fixed using MEMFA (1× minimum
essential medium (MEM) salt, 4% formaldehyde) solution. The fixed embryos were washed
with TBST (1× Tris-buffered saline, 0.1% Triton X-100) and then incubated in a blocking solu-
tion (10% fetal bovine serum (FBS), 2% dimethyl sulfoxide in TBST) for 30 minutes at room
temperature, followed by incubation with primary antibodies at 4˚C overnight. Next, the
embryos were washed with TBST and incubated with secondary antibodies for an hour.
Immunofluorescence analysis was performed with the following antibodies: anti-GFP (Abcam
ab13970), anti-α-tubulin (DSHB 6G7), anti-actin (DSHB JLA20), WGA-Alexa 488 (Molecular
probes, W11261), and anti-Muc5ac (Abcam ab77576) as primary antibodies. The stained
embryos were imaged using a confocal microscope (Zeiss LSM880). Images were analyzed
using Zen (Zeiss).
Cell culture
Human lung epithelial cells, Calu-3 (ATCC HRB-55), were cultured in Dulbecco’s Modified
Eagle’s medium (DMEM) (Lonza 12-604F). For RT-PCR, the cells were split into six-well
plates and harvested for RNA extraction. For immunofluorescence analysis, the cells were
split on a coverslip in six-well plates. Thapsigargin (1 μM) and narasin (2 μM and 4 μM) were
used. After 3 hours of incubation, the cells were harvested for RT- PCR or fixed using 4%
formaldehyde.
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Quantitative RT-PCR
Total RNA was extracted using a PureLink RNA mini kit (Invitrogen 12183018A), and the
cDNA was synthesized using a random primer (NEB S1330S) and GoScript Reverse Tran-
scriptase (Promega A50047). Quantitative RT-PCR was performed using the LightCycler 480
instrument (Roche LC480). The expression of ER stress marker genes was used to assess ER
stress levels after normalization to GAPDH expression (internal control) (GAPDH forward:
50-GGCCTCCAAGGAGTAAGACC-30, backward: 50-AGGGGTCTACATGGCAACTG-30; CHOP
forward: 50-GGAGCATCAGTCCCCCACTT-30, backward: 50-TGTGGGATTGAGGGTCACA
TC-30; IRE1 forward: 50-TGCTTAAGGACATGGCTACCATCA-30, backward: 50-CTGGAA
CTGCTGGTGCTGGA-30; PERK forward: 50-AATGCCTGGGACGTGGTGGC-30, backward:
50-TGGTGGTGCTTCGAGCCAGG-30; spliced XBP1 forward: 50-CGCTTGGGGATGGATGCC
CTG-30, backward: 50-CCTGCACCTGCTGCGGACT-30; total XBP1 forward: 50-GGCATCCT
GGCTTGCCTCCA-30, backward: 50-GCCCCCTCAGCAGGTGTTCC-30).
Results
1. Xenopus laevis: An alternative model system for studying muco-ciliary
epithelium
The mouse tracheal epithelium and human bronchial cells are frequently used to study the
muco-ciliary epithelium. The mouse model is well-established as a means of exploring the
pathophysiology of the muco-ciliary epithelium; however, in vivo mouse models or primary
air-liquid interface (ALI) culture systems require cautious handling and a considerable
amount of resources. Cancer cell lines provide alternative and compensatory models for study-
ing the muco-ciliary epithelium; however, cancer cell lines are not physiologically relevant in
certain contexts. Therefore, the muco-ciliary epithelium of Xenopus embryonic tissue is an
excellent alternative model system that provides an accessible source of tractable tissues for
investigating the pathophysiology of human respiratory disorders [9, 11]. The goblet cells con-
stitute approximately 50% of the Xenopus embryonic epidermal cells (Fig 1). The genetic and
physiological characteristics of Xenopus goblet cells are very similar to those of human tracheal
goblet cells [9, 12]. Xenopus goblet cells secrete mucins and ions to protect the embryonic skin
from environmental contaminants [5]. The secreted mucus components are constantly washed
off in the surrounding media. In addition, Xenopus embryos do not require a complex serum-
based culture media and can be nourished in minimally salted water, which is suitable for the
detection of mucus components in the media using enzyme-linked lectin assay (ELLA)-based
methods.
2. In vivo screening system using Xenopus laevis
Owing to the complexity of culture conditions and detection protocols, current research mod-
els such as primary cells cultured at the air-liquid interface or immortalized cell lines are not
suitable for unbiased massive screening for muco-active regents [4]. The abundance and sim-
ple culture conditions of the embryonic muco-ciliary epidermis of Xenopus embryos may pro-
vide a suitable alternative for high-throughput screening-based strategies. For identification of
muco-active reagents from unbiased chemical libraries using a high throughput approach, we
first examined if the secreted mucus level in Xenopus embryo culture media can be efficiently
detected by ELLA (Fig 2A). The major components of secreted mucus are glycosylated pro-
teins such as mucins. Lectins specifically bind to glycosylated oligosaccharides and have been
frequently used to detect glycosylated proteins in mucus [4]. In this method, the secreted
mucus in the media is detected directly using horseradish peroxidase-fused wheat germ
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agglutinin (WGA-HRP), a lectin. WGA specifically binds to the N-acetylglucosamine residues
on glycosylated proteins and has been used to determine mucus levels in human airway epithe-
lium [4]. HRP was used for colorimetric reaction and detection (Fig 2B).
We cultured Xenopus embryos in a multi-well plate and collected the media to determine
levels of secreted glycoprotein. Since the Xenopus culture media contains minimal salt and no
serum-based complex medium and proteins, ELLA was more suitable for the accurate detec-
tion of secreted glycoproteins. Indeed, the ELLA absorbance values show a linear correlation
with increasing doses of culture media in a certain range (Fig 2C).
3. The in vivo screening system yielded several muco-active reagents
Since the in vivo screening system using Xenopus embryos can be used to efficiently analyze
the mucus secretion level, we examined a SCREEN-WELL natural product library (Enzo
BML-2865) and a 10 mM Diversity Set provided by the National Cancer Institute’s (NCI)
Developmental Therapeutic Program’s Open Compound Repository, to identify compounds
that regulate mucus secretion. The final concentration of the chemicals used was 15 μM.
Embryos were incubated in the media with individual chemicals for 3 hours, after which they
were moved to new media which were without the chemicals. After 1 hour of further incuba-
tion, the media was collected for ELLA based-mucus detection. The graph represents the ratio
of optical density measurements of drug-treated media and the averaged control media in
Fig 1. The composition of the muco-ciliary epithelium of Xenopus laevisembryo. A. Immunofluorescence image of mucus secreting goblet cells and multiciliated cells
in Xenopus embryonic epidermis. The membrane was stained using membrane GFP (green), Cilia were detected using α-tubulin (red) and actin by anti-actin antibody
(green).
https://doi.org/10.1371/journal.pone.0193310.g001
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ELLA. Data were analyzed by calculating the Z-score representing the differences of individual
values from the mean value. Using this new strategy, we tested approximately 600 natural com-
pounds and 200 synthetic chemicals. While none of the chemical compounds from the Diver-
sity Set provided by the National Cancer Institute made any significant changes in ELLA
signal intensity, the natural compound library yielded several compounds that potentially
affected mucus levels (Fig 3A and 3B).
4. Identification of possible muco-regulators
Next, we selected four natural compounds that significantly affected the mucus secretion level
and systemically examined the muco-regulating activities of the individual compounds. To
investigate the effect of the selected candidates on mucus secretion in further detail, the cells
were treated with various doses of the chemicals and the secreted mucus levels were deter-
mined using the WGA-HRP-based ELLA protocol. Indeed, all four candidates considerably
affected mucus secretion from the Xenopus embryonic epidermis (Fig 4).
Phorbol 12, 13-dibutyrate and bicuculline increased, whereas phodophyllotoxin and nara-
sin decreased the secreted mucus level in the media (Fig 4). Among these chemicals, phorbol
12, 13-dibutyrate was previously reported to increase glycoprotein secretion from goblet cells
Fig 2. High throughput screening strategy for muco-active reagents from the compounds library using Xenopus embryos. A. Schematic showing the drug screening
procedure. Sibling Xenopus embryos were incubated with individual compounds in the library. Then, the media was collected after washing off the compound from the
media. The mucus in the media was detected using WGA-HRP and mucus level was analyzed by measuring the optical density (OD) of the HRP substrates. B. Schematic
showing the mucus detection procedure using WGA-HRP in ELLA. WGA-HRP can detect the glycosylated region of mucus in the media. C. Dose-dependent linear
correlation of OD values with the amount of media used for mucus detection in ELLA.
https://doi.org/10.1371/journal.pone.0193310.g002
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by activating protein kinase C (PKC) [13, 14]. Bicuculline was also previously reported to regu-
late mucus secretion. Interestingly, however, bicuculline is known to inhibit mucus secretion
by antagonizing GABA signaling [15]. We speculated that bicuculline may reversibly inhibit
mucus secretion, and the retained mucus is possibly released in the medium after washing
off bicuculline. Indeed, the secreted mucus level was reduced in the presence of bicuculline;
however, mucus secretion increased after exchanging the media with bicuculline-free media
(Fig 4B).
Also, we performed a time-course analysis of the mucus secretion upon the treatment of
the bicuculline and after removing bicuculline respectively (Fig 5). Indeed, the reduced mucus
secretion by treating bicuculline, was recovered within one hour after removing bicuculline.
These results show that the physiological properties of the Xenopus muco-ciliary epidermis are
similar to those of the mammalian airway epithelium, and that our screening protocol can
effectively and unbiasedly detect muco-active reagents.
5. Narasin disrupts mucus secretion and causes mucus accumulation in the
intracellular compartment
We further analyzed the changes in mucus granules in goblet cells after treating these four
muco-active chemicals to the Xenopus embryos by staining them with WGA-Alexa 488 (Fig
6A). Among the four muco-active chemicals, the retention of mucus in narasin-treated goblet
Fig 3. High throughput screening yielded putative muco-active reagents from the compounds library. A. The result of natural compound library screening. Data were
analyzed by calculating the Z-score which indicates how far an individual score is away from the mean of a data set. Four putative muco-active reagents which have a Z-
score over 4 or below -4 were selected for further analysis. B. The screening results of a random chemical library from NCBI. The random chemical library did not yield
any muco-active reagents.
https://doi.org/10.1371/journal.pone.0193310.g003
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Fig 4. Putative muco-active reagents affecting mucus secretion level. The mucus level in the media upon the treatment of increasing doses of individual chemicals was
normalized to those of control embryos and plotted on the graph (left panel, n = 5). The secreted mucus levels at 50uM of each natural compound were plotted (right
panel, n = 39). P-values were calculated from student’s t-test. A. Phorbol 12,13-dibutyrate is a known activator of PKC and promotes mucus secretion. B. Bicuculline is a
GABA antagonist and inhibits mucus secretion. In the presence of bicuculline, mucus secretion was strongly inhibited (rectangle line); however, mucus secretion
recovered after removing bicuculline (circle line). C. Podophyllotoxin is a known microtubule polymerization inhibitor with anti-viral and anti-tumor activities.
Podophyllotoxin strongly inhibited mucus secretion from the Xenopus embryonic epithelium. D. An ionophoric coccidiostat, narasin inhibits mucus secretion.
https://doi.org/10.1371/journal.pone.0193310.g004
Fig 5. Bicuculline reversibly inhibits mucus secretion. Mucus secretion was analyzed in the presence of 50uM of bicuculline (A) or after changing the media
without bicuculline at every 30 min (B). Mucus secretion was restored within 1 hour after removing bicuculline. P-values were calculated from student’s t-test
(n = 4).
https://doi.org/10.1371/journal.pone.0193310.g005
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cells was particularly interesting (Fig 6A, left panel). Narasin is an ionophoric coccidiostat
used to treat and protect poultry animals from coccidial infections. We further examined
mucus retention after treating other known coccidiostats such as monensin and nigericin.
Indeed, both monensin and nigericin accumulated mucus granules in the goblet cells of Xeno-
pus epidermis (Fig 6B). We confirmed the mucus retention by performing western blot analy-
sis using WGA-HRP (Fig 6C).
The muco-active functions of narasin were not previously reported. Therefore, we further
assessed narasin’s muco-regulatory activity using human mucus-secreting Calu-3 cells. The
Calu-3 cells are frequently used to study mucus secretion in vitro [16]. We treated Calu-3 cells
with narasin for 2 hours and determined the intracellular glycoprotein levels by analyzing the
WGA-Alexa488 fluorescent signals. Indeed, the intensity of the WGA-Alexa488 signal was sig-
nificantly higher in narasin-treated Calu-3 cells than in the control cells (Fig 7A and 7B). Next,
we used immunofluorescence imaging analysis to determine whether Muc5ac also accumu-
lated intracellularly in narasin-treated cells. As expected, the narasin-treated Calu-3 cells accu-
mulated larger quantities of Muc5ac than the mock-treated Calu-3 cells (Fig 7A and 7C).
Finally, we sought to understand the underlying mechanism of narasin’s role in mucus
retention. Narasin exposure is known to increase endoplasmic reticulum (ER) stress in cancer
cells [17]. We speculated that an increase in ER stress may perturb normal secretory pathways
or Muc5ac processing upon narasin treatment. We monitored changes in ER stress signals
after narasin treatment. However, as shown by comparison to the control samples, narasin
treatment did not strongly affect ER stress levels in either Calu-3 cells (Fig 7D) or Xenopus (Fig
7E). In addition, thapsigargin treatment, which is known to increase ER stress responses, did
not strongly alter intracellular mucus levels of Muc5AC and glycoproteins (Fig 7A, 7B and
Fig 6. Ionophoric antibiotics narasin inhibits mucus secretion. A. The mucus granules were stained with WGA-Alexa 488 to visualize retained mucus granules. Narasin
treated goblet cells (last panel) displayed severe retention of mucus granules. B. Ionophoric antibiotics, Monensin and Nigericin, inhibit mucus secretion similar to
narasin. C. Narasin treatment increased intracellular levels of glycosylated protein.
https://doi.org/10.1371/journal.pone.0193310.g006
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7C), although it significantly increased ER stress signals (Fig 7D and 7E), which were assessed
by measuring the expression of ER stress response genes using quantitative real time-poly-
merase chain reaction (RT-PCR). These results suggest that narasin may directly affect
mucus secretion, which excludes the involvement of ER stress-associated secondary mucus
production.
Discussion
In this study, we exploited the advantages of the Xenopus embryonic epithelium to develop an
unbiased drug discovery strategy for novel muco-active reagents. Indeed, our novel technique
Fig 7. Narasin inhibits mucus secretion in Calu-3 cells. A. Narasin-treated Calu-3 cells were stained with WGA (green) and Muc5ac (Red). Narasin-treated Calu-3 cells
accumulated Muc5ac-positive puncta and WGA-stained glycoproteins in the cytosol. B. The number and average size of WGA stained signal was plotted graphically. C.
The number of Muc5ac stained puncta was measured and represented graphically. D. Although the PERK level was slightly increased, ER stress was not strongly induced
by narasin in Calu-3 cells. Thapsigargin induced strong ER stress response but mucus secretion was not affected. E. Narasin did not severely induce ER stress responses in
Xenopus embryos. P-values were calculated from student’s t-test using the triplicate Q-PCR data set. A.U.; Arbitrary unit.
https://doi.org/10.1371/journal.pone.0193310.g007
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efficiently and effectively detected changes in mucus levels in the nourishing media by a simple
two-step analysis procedure involving WGA-HRP detection and chromogenic measurement.
Furthermore, we tested the muco-regulatory activities of a natural compound library to vali-
date our high throughput screening procedure, which is currently challenging in other popular
model systems such as the HBEC ALI culture or mouse models. We have identified several
muco-active reagents from this pioneering natural compound library screening. Among sev-
eral candidates, two chemicals, phorbol 12,13-dibutyrate and bicuculline, are known to control
mucus secretion as a PKC activator and GABA receptor antagonist respectively. These data
validated the effectiveness of our technique. In addition, we identified a novel muco-active
compound called narasin, which can possibly be used as a therapeutic for respiratory diseases.
Genomic analysis in Xenopus tropicalis, revealed a huge expansion of Muc genes in its genome
[8]. Apparently, Xenopus genome contains 26 gel forming mucin genes including 12 Muc2
genes (Muc2A-L), and 11 Muc5 genes (Muc5A-K). Although, the Muc genes in Xenopus are
highly evolved and differ structurally from those of humans, our data suggest the secretory
mechanism may be conserved in Xenopus and can be used to discover the muco-regulator
affecting mucus secretion from the goblet cells. Further research on the physiology and molec-
ular mechanism of Muc gene regulation in Xenopus would strengthen the utility of embryonic
epidermis as an alternative model system to study mucociliary epithelium.
Abnormalities in muco-regulation are one of the most frequently observed symptoms in
respiratory disorders. Therefore, novel reagents that effectively regulate mucus secretion from
the airway epithelium are being actively researched. However, current muco-regulation
research models do not provide high throughput screening protocols for identification of
muco-regulators in an unbiased manner. In this study, we developed a cost-efficient and unbi-
ased strategy targeting muco-active reagents using Xenopus embryonic epidermis.
The embryonic epidermis of Xenopus has been extensively used to study multicilia as a trac-
table and alternative model. In addition, several types of secretory cells such as the goblet cells,
ionocytes, and small secretory cells are also in the limelight for research on muco-regulation.
The Xenopus embryonic epidermis possesses several advantages compared to other research
models such as human bronchial epithelial cells (HBEC) and the mouse model. One Xenopus
female can produce thousands of embryos per day, which generates an unlimited source of
research material. Unlike HEBCs, which take several weeks to differentiate into the muco-cili-
ary epithelium in ALI culture, the Xenopus embryonic epidermis differentiates to a completely
functional muco-ciliary epithelium within two days. The mouse airway epithelium is an excel-
lent in vivo model; however, internal organs are not suitable for massive drug screening pur-
poses, as they require a substantial amount of labor and resources. In contrast, the Xenopus
embryonic epidermis is located on the external skin of embryos, and is favorable for experi-
mentally analyzing muco-regulation. Moreover, Xenopus embryos grow in minimally salted
water and the secreted mucus can be accurately and simply measured using ELLA.
Narasin is an ionophoric antibiotic used for treating coccidial infections in poultry and live-
stock. Although narasin is widely used in farm animal feed, its cytotoxic effects on several
organs such as the cardiovascular, muscular, and gastrointestinal systems have been reported.
However, the underlying mechanism of its cytotoxicity is not yet understood. In this study, we
observed that narasin severely alters mucus secretion and induces accumulation of mucus
granules in the cytosol. Our data suggest that the inhibitory effect of narasin on mucus secre-
tion is not due to secondary effects stemming from ER stress responses, which was previously
shown to be induced by narasin in a human cell line. Extensive research is required to under-
stand the underlying mechanisms of the muco-regulatory activity of narasin.
The muco-ciliary epithelium of the airway tract is one of the most vulnerable tissues of the
human body and mucus hypersecretion is one of the major symptoms of respiratory disorders.
Xenopus: An alternative model system for identifying muco-active agents
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We believe that the high throughput screening strategy developed in this study will accelerate
the identification of effective muco-regulators with novel functions and mechanisms.
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